The Therapeutic Goods Administration (TGA) has issued 2 infringement notices totalling $37,560 to Booty N Buff Nutrition Caringbah Pty Ltd (Booty N Buff Nutrition) for the alleged unlawful advertising of therapeutic goods in contravention of the Therapeutic Goods Act 1989 (the Act).
Booty N Buff Nutrition paid the infringement notices in December 2025.
It is alleged that Booty N Buff Nutrition unlawfully advertised sports supplements that were not included in the Australian Register of Therapeutic Goods (ARTG) which contained the Schedule 4 prescription-only substances tryptophan and levodopa.
Therapeutic goods not entered in the ARTG have not been assessed for their quality and safety by the TGA and may pose a health risk.
In Australia, Schedule 4 substances are classified as prescription-only due to the risk of harm and the level of access control required to protect public health and safety. The decision to use a particular prescription-only medicine should be made between the prescribing health practitioner and the patient based on informed consent, including a discussion about possible side effects. Advertising prescription-only medicines directly to consumers is prohibited under the Act.
Businesses must understand their legal obligations under the Act before manufacturing, supplying or advertising therapeutic goods. Consequences for non-compliance may include infringement notices, direction notices, or civil or criminal proceedings.
The TGA will continue to take action where serious non-compliance with the Act is identified in accordance with our regulatory compliance framework.
If you suspect non-compliance in relation to therapeutic goods, or their advertising, you can report it to the TGA at any time.
